Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
The development of gastric enterochromaffin-like (ECL)-cell hyperplasia in humans may be associated with extreme hypergastrinaemia, as occurs in Zollinger-Ellison syndrome (ZES) and pernicious anaemia (type A gastritis). More recently, endocrine cell hyperplasia has been found in all forms of chronic atrophic gastritis and even in cases of focal atrophy. Serum gastrin levels, non-antral gastric endocrine (argyrophil) cell growth, and the severity and type of concomitant gastritis were monitored in 66 unoperated and 8 antrectomized patients with poorly responsive peptic ulcer or reflux oesophagitis during up to 5 years' treatment with high-dose omeprazole, 40 mg daily. A small subgroup of patients (23%) had serum gastrin concentrations of more than four times the normal upper limit. These patients also had hyperplasia of the gastric argyrophil cells. More importantly, the same subgroup of patients had high-grade (atrophic) gastritis. Micronodular hyperplasia of argyrophil cells was significantly more frequent in biopsies showing atrophic gastritis (48%) than in biopsies showing only superficial gastritis (3.6%). It is concluded that, as previously demonstrated in untreated patients with gastric ulcer, the argyrophil cell hyperplasia observed during high-dose omeprazole therapy is related to the progression of chronic atrophic gastritis rather than to serum gastrin levels.
Creutzfeldt
W
W
Department of Medicine, Georg-August University of Göttingen, Germany.
Lamberts
R
R
D001706:Biopsy; D004942:Esophagitis, Peptic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D005753:Gastric Mucosa / Q000473:pathology*; D005755:Gastrins / Q000097:blood* / Q000187:drug effects; D005757:Gastritis, Atrophic / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D006965:Hyperplasia; D008137:Longitudinal Studies; D009853:Omeprazole / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012720:Severity of Illness Index
D005755:Gastrins; D009853:Omeprazole